Jim Cunningham – 2016 Parliamentary Question to the Department of Health
The below Parliamentary question was asked by Jim Cunningham on 2016-06-08.
To ask the Secretary of State for Health, what estimate his Department has made of the amount paid by the NHS to pharmaceutical companies for prescription drugs in each of the last 10 years; and if he will make a statement.
Alistair Burt
The information requested is in the table.
Year |
Primary care drugs spend (1) |
Secondary care drugs spend |
Total drugs spend |
Outturn (£ m) |
Outturn (£ m) |
Outturn (£ m) |
|
2004/05 |
7,376 |
2,595 |
9,971 |
2005/06 |
7,235 |
2,764 |
9,999 |
2006/07 |
7,593 |
2,969 |
10,562 |
2007/08 |
7,663 |
3,274 |
10,937 |
2008/09 |
7,749 |
3,647 |
11,397 |
2009/10 |
7,946 |
3,974 |
11,920 |
2010/11 |
8,280 |
4,257 |
12,537 |
2011/12 |
8,243 |
4,482 |
12,725 |
2012/13(2) |
7,887 |
5,055 |
12,941 |
2013/14(3) |
8,015 |
5,324 |
13,339 |
2014/15 |
8,206 |
5,897 |
14,103 |
Sources:
- Primary care figures to 2012-13 are from Primary Care Trusts (PCTs) audited summarisation schedules. Figures from 2013-14 are from the Department’s annual report and accounts.
- Secondary care figures are from National Health Service trusts, PCT finance returns and foundation trust year-end accounts. Finance returns were not collected after 2011/12; figures for NHS trusts in 2012/13 are estimates.
- Secondary care figures from 2013-14 are from Monitor and NHS Trust Development Authority.